Anzeige
Mehr »
Login
Dienstag, 11.02.2025 Börsentäglich über 12.000 News von 685 internationalen Medien
US-Biotech-Firma sorgt für Furore - steckt hier die Zukunft der Krebsheilung?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2JNLV | ISIN: CA46604F1099 | Ticker-Symbol: 1R3
Tradegate
11.02.25
08:01 Uhr
0,209 Euro
+0,017
+8,85 %
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
IZOTROPIC CORPORATION Chart 1 Jahr
5-Tage-Chart
IZOTROPIC CORPORATION 5-Tage-Chart
RealtimeGeldBriefZeit
0,1710,20816:23
0,1740,20516:08

Aktuelle News zur IZOTROPIC Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
IZOTROPIC Aktie jetzt für 0€ handeln
FrIzotropic Corp: Izotropic arranges $360,000 private placement2
FrIzotropic Corporation: Izotropic Announces Non-Brokered Private Placement270THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESVancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 7, 2025)...
► Artikel lesen
DoIzotropic Corp: Izotropic CEO cancels OTC conference over emergency8
DoIzotropic Corporation: Izotropic Reschedules Investor Conference Presentation to March 13th393Vancouver, British Columbia and Sacramento, California--(Newsfile Corp. - February 5, 2025) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device...
► Artikel lesen
03.02.Izotropic Corporation: Izotropic to Present at Investor Conference February 6th218- CEO to present overview of Company value proposition, unique catalysts, and near-term objectives -- Event includes live Q and A, attendance is complimentary -- Individual and institutional investors...
► Artikel lesen
30.01.Izotropic Corp: Izotropic talks timeline for medical imaging device4
29.01.Izotropic Corporation: Izotropic Announces Timelines and Milestones to IzoView Product Launch203- Unique dense breast tissue focus to drive expedited recruitment rates; modular clinical study design reduces time to PMA submission by ~6 months -- 3 Site U.S.-based clinical study enables early...
► Artikel lesen
17.01.Izotropic Corporation: Izotropic Featured in Announcement of Research and Markets' U.S. Breast Cancer Analysis and Forecast368- Company listed in Research and Markets' announcement and description of new research report on the U.S. Breast Cancer Screening and Diagnostic Market- - "U.S. breast cancer screening and diagnostic...
► Artikel lesen
15.01.Izotropic Corp: Izotropic hires Myers, Toledano, DeLucia for consulting6
15.01.Izotropic Corporation: Izotropic Announces Team Leading Clinical Study Design and FDA Regulatory Submissions208-New FDA Consultant is the former Director of the Division of Imaging, Diagnostics, and Software Reliability at the U.S Food and Drug Administration--New Biostatistical Consultant is the former Deputy...
► Artikel lesen
09.01.Izotropic Corp: Izotropic files presubmission with FDA for IzoView4
09.01.Izotropic Corporation: Izotropic Files Pre-Submission with U.S. FDA for Breast Cancer Screening251-A screening indication for women with dense breast tissue adjunctive to 3D mammography increases the market size for annual IzoView scans by over 800%1 for initial approval and product launch- -Regulatory...
► Artikel lesen
31.12.24Izotropic Corp: Izotropic shareholders approve all matters at AGM13
04.12.24Izotropic Corporation: Izotropic Provides Update on Annual General Meeting Materials and Voting Procedures 311Vancouver, British Columbia--(Newsfile Corp. - December 4, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing...
► Artikel lesen
19.11.24Izotropic Corp: Izotropic closes $140,000 private placement13
13.11.24Izotropic Corp: Izotropic arranges $125,000 private placement16
23.08.24Izotropic Corp: Izotropic tweaks U.S., EU regulatory plans for IzoView6
23.08.24Izotropic to launch Izoview for breast cancer diagnostics7
23.08.24Izotropic Corporation: Izotropic Announces Regulatory Approval Plans to Launch Izoview for Breast Cancer Diagnostics in Patients with Dense Breasts in the U.S. and EU1.022Vancouver, British Columbia--(Newsfile Corp. - August 23, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company"), a medical device company commercializing...
► Artikel lesen
14.06.24Izotropic Corporation Announces Closing of First Tranche of Non-Brokered Private Placement378Vancouver, British Columbia--(Newsfile Corp. - June 14, 2024) - Izotropic Corporation (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3) ("Izotropic" or the "Company") - Further to the Company's news release of...
► Artikel lesen
Seite:  Weiter >>
21 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,3